Status:
COMPLETED
Evolution of Pulmonary Ultrasound in Patients Hospitalized for Covid (Coronavirus Disease) 19
Lead Sponsor:
Centre Hospitalier Intercommunal Creteil
Conditions:
Pneumonia, Viral
COVID-19
Eligibility:
All Genders
18-105 years
Brief Summary
Clinical thoracic ultrasound plays an important role in the exploration, diagnosis and follow-up of thoracic pathologies. The COVID (Coronavirus Disease) epidemic is leading to a large influx of pati...
Detailed Description
Chest ultrasound has already shown its value in the diagnosis of pneumonia in the emergency department with superiority over chest X-ray. However, there is little data on the thoracic ultrasound semi...
Eligibility Criteria
Inclusion
- Patients admitted to hospital with proven COVID-19 infection with respiratory signs warranting a chest CT scan
Exclusion
- Patient not agreeing to have his or her data collected for the study
- Unconscious patient
Key Trial Info
Start Date :
March 31 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2020
Estimated Enrollment :
106 Patients enrolled
Trial Details
Trial ID
NCT04341766
Start Date
March 31 2020
End Date
June 30 2020
Last Update
July 17 2020
Active Locations (17)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Amiens
Amiens, France, 80054
2
CH de la Côte Basque
Bayonne, France, 64109
3
CHU Ambroise Paré
Boulogne-Billancourt, France, 92104
4
CHU Caen
Caen, France, 14033